impacted our EOEG facility at Clear Lake, Texas and lowered HVA and Necessity production by over 45KT during a strong margin environment. Since startup, the plant is performing well into 3Q17 with margins
. PET production at Poland and Alphapet USA were also impacted due to temporary shutdowns as well as an extended shutdown of the EO-EG facility. All these facilities are now back on stream. Core
and teething issues. Feedstock portfolio also benefited from higher production from the EO-EG facility in USA in 2H17 post catalyst change in 1H17. Production of PTA was higher in Asia which benefitted
terms of the production in 2018, the Company still continues its operation and produces Hot Rolled Coils. Further, the Company is in the process of obtaining the new facility which was submitted to the
the new facility which was submitted to the Central Bankruptcy Court for an approval. Once the new loan is approved, the Company will be able to continue its production continuously as per budgeting
working capital in business operation, sourcing raw materials, and increase Company’s production capacity. The interest rate of this loan can be divided into 3 categories as follow; 1. Funded portion at 12
fund as working capital in business operation, sourcing raw materials, and increase Company’s production capacity. The interest rate of this loan can be divided into 3 categories as follow; 1. Funded
production from its ethylene cracker in Louisiana, USA. This cracker will mainly support the captive EO-EG facility providing unique integration advantage and the ability to capture the entire value chain